Cannara Biotech (OTC:LOVFF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Cannara Biotech Stock (OTC: LOVFF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 13.14K
Day Range	- - -
52 Wk Range	0.39 - 0.78
Market Cap	$49.51M
P/E Ratio	11.24
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Nicolás Jose Rodriguez

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.

Nicolás Jose Rodriguez

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability

Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended Aug. 31. The Montreal, Canada-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million). Gross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments. Positive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 13.14K
Day Range	- - -
52 Wk Range	0.39 - 0.78
Market Cap	$49.51M
P/E Ratio	11.24
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cannara Biotech (LOVFF) stock?

You can purchase shares of Cannara Biotech (OTCQB:LOVFF) through any online brokerage.

View our list of the best stock brokerages

Who are Cannara Biotech (LOVFF) competitors?

There are no as such competitors for Cannara Biotech.

What is the forecast, or price target, for Cannara Biotech (LOVFF) stock?

There is no analysis for Cannara Biotech to provide a consensus price target.

What is the current price for Cannara Biotech (LOVFF)?

The stock price for Cannara Biotech (OTCQB: LOVFF) is $0.55 last updated December 20, 2024 at 12:32 PM EST.

Does Cannara Biotech (LOVFF) pay a dividend?

There are no upcoming dividends for Cannara Biotech.

When is Cannara Biotech (OTCQB:LOVFF) reporting earnings?

Cannara Biotech does not have any upcoming earnings scheduled.

Is Cannara Biotech (LOVFF) going to split?

There is no upcoming split for Cannara Biotech.

What sector and industry does Cannara Biotech (LOVFF) operate in?

Cannara Biotech is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Comments

Cannara Biotech

Cannara Biotech (LOVFF) Forecast